Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


Sensex Opens Higher; Oil & Gas Stocks Lead
Fri, 26 Jun 09:30 am

Asian stock markets are trading mixed today. Australian S&P 200 futures rose 1.2% in early trading. Japan's Nikkei 225 futures added 0.1%. Hong Kong's Hang Seng index futures lost 0.9%.

Wall Street's main indices closed higher in choppy trading on Thursday, with bank stocks soaring ahead of annual stress test results and helping to offset investor jitters over alarming increases in new coronavirus cases.

Back home, Indian share markets opened on a positive note.

The BSE Sensex is trading up by 247 points. The NSE Nifty is trading up by 70 points.

Meanwhile, the BSE Mid Cap index has opened up by 0.8%.

BSE Small Cap index is trading higher by 0.5%.

All sectoral indices are trading in the green with BSE Oil & Gas witnessing maximum buying interest.

Moving on, the rupee is currently trading at 75.55 against the US$.

Gold prices are currently trading down by 0.4% at Rs 47,941.

Moving on to the stock specific news...

Piramal group stocks and HUL are among the top buzzing stocks today.

As per an article in a leading financial daily, the Carlyle Group has emerged as the frontrunner to buy a significant stake in the Piramal Group's pharma businesses for close to Rs 35 billion.

Reportedly, American private equity giants TPG Capital and KKR & Co. Inc. too were in the fray, looking to invest Rs 35-40 billion for acquiring a 20% stake in Piramal Group's proposed pharmaceutical entity that would combine the group's pharma businesses.

As per Piramal's current strategy, the pharma businesses will be demerged from Piramal Enterprises Ltd. and combined into a new entity, 20% of which will be owned by Carlyle and possibly another private equity investor, while at least 25% will be owned by the public and the remainder will remain with the promoters.

The stake sale, once completed, may value the Piramal Group's overall pharma business at approximately US$2.5 billion.

Piramal Group has been in discussions with several potential investors for a stake sale in its pharma business over the past few months.

The stake sale is part of the group's larger plan to demerge all pharma businesses, bring them under a single subsidiary and, eventually, list it on the exchanges.

How this pans out going forward remains to be seen. Meanwhile, we will keep you updated on the developments from this space.

Piramal Enterprises share price opened the day down by 0.3%.

In another news from pharma sector, Dr Reddys Laboratories has said it is working on four new products that are in the final stage beside some early-stage drugs.

The products' segment focuses on research and development, and commercialization of different formulations.

The new compounds are in the therapeutic areas of paediatrics, dermatology, hematology-oncology, the reports npted.

DFD-11(Xeglyze) in the pediatrics area is intended for the treatment of head lice in patients six months of age or older. PPC-06 (Tepilamide Fumarate) in dermatology is for the treatment of plaque psoriasis in patients 18 years of age or older.

Reportedly, as of March 2020, the company has had four late-stage projects at various stages of development ranging from products that have completed Phase-2 clinical trials to products that are undergoing investigation for USFDA approval.

Dr. Reddy's share price opened up by 0.4%.

Here's an interesting data on Dr. Reddy's Lab, investing just Rs 100,000 in Dr. Reddy's Labs in 1992, it would have given a whopping Rs 4.89 crores in 2014!


Co-head of Research, Tanushree Banerjee believes, the opportunities in the Rebirth of India are not only more profitable than the ones in 1991 but the gains could come faster too.

Hindustan Unilever share price is also in news today after the company informed that it would stop using the word 'Fair' in its 'Fair & Lovely' skin cream, in a move that comes after years of protests that it promotes prejudice over skin colour.

The new name is awaiting regulatory approvals and will be adopted in the next few months.

First introduced in India decades ago, Fair & Lovely became a bestselling product, racking up sales of about Rs 40 billion last year as it tapped into the perspective that equated fairness with beauty.

That positioning was criticised by many for promoting colourism in a country where a large part of the population is brown-skinned.

Soon after HUL's announcement, Emami, which owns the 'Fair & Handsome' brand said it values consumer sentiments and take cognizance of the holistic approach that is required to be taken to address their needs.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex Opens Higher; Oil & Gas Stocks Lead". Click here!